Marathon Trading Investment Management LLC acquired a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 4,580 shares of the insurance provider’s stock, valued at approximately $1,162,000.
Several other institutional investors and hedge funds have also modified their holdings of HUM. Janney Montgomery Scott LLC lifted its holdings in Humana by 11.6% in the third quarter. Janney Montgomery Scott LLC now owns 3,721 shares of the insurance provider’s stock valued at $1,179,000 after acquiring an additional 388 shares during the period. Van ECK Associates Corp purchased a new position in shares of Humana during the 3rd quarter valued at approximately $424,000. Principal Financial Group Inc. lifted its stake in shares of Humana by 2.4% in the 3rd quarter. Principal Financial Group Inc. now owns 170,636 shares of the insurance provider’s stock valued at $54,047,000 after purchasing an additional 3,961 shares during the period. Assetmark Inc. boosted its holdings in Humana by 19.4% during the third quarter. Assetmark Inc. now owns 14,723 shares of the insurance provider’s stock worth $4,663,000 after buying an additional 2,392 shares in the last quarter. Finally, Atria Investments Inc grew its position in Humana by 18.1% during the third quarter. Atria Investments Inc now owns 5,552 shares of the insurance provider’s stock valued at $1,759,000 after buying an additional 851 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.
Insider Activity at Humana
In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.32% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
View Our Latest Stock Report on HUM
Humana Price Performance
Shares of HUM opened at $251.41 on Tuesday. The firm has a 50-day simple moving average of $271.74 and a two-hundred day simple moving average of $282.37. The stock has a market cap of $30.33 billion, a PE ratio of 25.27, a P/E/G ratio of 2.05 and a beta of 0.57. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.
Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, analysts forecast that Humana Inc. will post 16.47 EPS for the current year.
Humana Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.41%. The ex-dividend date is Friday, March 28th. Humana’s payout ratio is 35.58%.
Humana Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles
- Five stocks we like better than Humana
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- How to Protect Your Portfolio When Inflation Is Rising
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.